Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Toon andere (1) versies

Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer�...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A
Andere auteurs:	International College of Geriatric Psychoneuropharmacology
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	John Wiley & Sons, Ltd. 2010
Onderwerpen:	Medical sciences Psychiatry

Gelijkaardige items

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
door: Oulhaj, A, et al.
Gepubliceerd in: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
door: Smith, A, et al.
Gepubliceerd in: (2010)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
door: de Jager, C, et al.
Gepubliceerd in: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
door: De Jager, C, et al.
Gepubliceerd in: (2012)

Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
door: Goodwin, G
Gepubliceerd in: (2003)

Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
door: Goodwin, G
Gepubliceerd in: (2003)

Homocysteine, B vitamins, and cognitive impairment
door: Smith, A, et al.
Gepubliceerd in: (2016)

Cholesterol-metabolism, plant sterols, and long-term cognitive decline in older people – Effects of sex and APOEe4
door: Matteo Spinedi, et al.
Gepubliceerd in: (2024-02-01)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
door: Smith, A, et al.
Gepubliceerd in: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
door: Smith, A, et al.
Gepubliceerd in: (2010)

Homocysteine – A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia
door: Ines Elisabeth Futschek, et al.
Gepubliceerd in: (2023-02-01)

Homocysteine, B vitamins, and cardiovascular disease
door: Refsum, H, et al.
Gepubliceerd in: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
door: Refsum, H, et al.
Gepubliceerd in: (2006)

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
door: Ballard, C, et al.
Gepubliceerd in: (2008)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
door: Oulhaj, A, et al.
Gepubliceerd in: (2016)

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
door: Martins, C, et al.
Gepubliceerd in: (2005)

Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism
door: Fullerton, J, et al.
Gepubliceerd in: (2003)

High dimensional endophenotype ranking in the search for major depression risk genes
door: Glahn, D, et al.
Gepubliceerd in: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
door: De Jager, C, et al.
Gepubliceerd in: (2012)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
door: Clarke, R, et al.
Gepubliceerd in: (1998)

MET and autism susceptibility: family and case-control studies
door: Sousa, I, et al.
Gepubliceerd in: (2009)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
door: Jones, S, et al.
Gepubliceerd in: (2017)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
door: A David Smith, et al.
Gepubliceerd in: (2010-09-01)

Investigating circadian disruption in mouse models of neurological and metabolic disorders
door: Livieratos, A
Gepubliceerd in: (2013)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
door: Belbin, O, et al.
Gepubliceerd in: (2009)

How can magnetoencephalography and magnetic resonance imaging improve our understanding of genetic susceptibility to Alzheimer's disease?
door: Heise, V
Gepubliceerd in: (2013)

Psychiatric, demographic and personality characteristics of elderly sex offenders
door: Fazel, S, et al.
Gepubliceerd in: (2002)

Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
door: Geetika Nehra, et al.
Gepubliceerd in: (2025-01-01)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
door: Olivia M. Osborne, et al.
Gepubliceerd in: (2023-08-01)

The cognitive neuropsychology of depression in the elderly
door: Herrmann, L, et al.
Gepubliceerd in: (2007)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
door: Nurk, E, et al.
Gepubliceerd in: (2005)

Using neuroimaging and histology to understand hyperexcitability and atypical connectivity in autism spectrum disorder
door: Ravishankar, M
Gepubliceerd in: (2015)

Effect of physical activity on anxiety and depression in COVID-19 adults: A systematic review and meta-analysis
door: Qingyuan Luo, et al.
Gepubliceerd in: (2024-10-01)

Caregiver Burden is Associated with Cognitive Decline and Physical Disability of Elderly Post-Stroke Patients
door: Othman, Zahiruddin, et al.
Gepubliceerd in: (2014)

Validation of the Malay Version of Short Informant Questionnaire on Cognitive Decline in the Elderly (MS-IQCODE)
door: Othman, Zahiruddin, et al.
Gepubliceerd in: (2015)

QEEG in affective disorder: about to be a biomarker, endophenotype and predictor of treatment response
door: Sermin Kesebir, et al.
Gepubliceerd in: (2018-08-01)

Alzheimer's Disease - A Comprehensive Review
door: Kinga Woźniak, et al.
Gepubliceerd in: (2024-02-01)

Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study
door: Luigi Zerbinati, et al.
Gepubliceerd in: (2022-10-01)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
door: Refsum, H, et al.
Gepubliceerd in: (2006)

Anti‐N‐homocysteine‐protein autoantibodies are associated with impaired cognition
door: Olga Włoczkowska, et al.
Gepubliceerd in: (2021-01-01)